Method of identifying a biologically-active composition from a biofilm

Inventors

Berkes, Eva A. • Monsul, Nicholas T. • BOEHM, Frederick T.

Assignees

Quorum Innovations Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-9713631-B2

Patent

Publication Date

2017-07-25

Expiration Date


Abstract

The subject invention provides materials and methods that effectively support innate immunity and/or disperse pathogenic biofilms using readily available, nontoxic, natural substances, while supporting restoration of normal microbiotic homeostasis. In one embodiment, the subject invention provides anti-biofilm compositions comprising one or more probiotic organisms, anti-microbial honey, and other ingredients such as prebiotic compounds, other hive products, green tea derivatives, other plant derivatives, and vitamin D3.

Core Innovation

The invention is directed to manipulating a microbiome and providing antimicrobial activity by contacting a microbiome or microbes with a biologically-active composition. The composition is produced by growing a microbial biofilm within a reactor vessel while the biofilm is contacted with a biological growth medium, then harvesting the biofilm by removing it from the reactor vessel to obtain a fraction comprising biologically-active biofilm cellular mass.

The harvested biofilm cellular-mass fraction is combined with an appropriate carrier to form the biologically-active composition used for microbiome manipulation or antimicrobial contacting. The disclosure also includes separating a fraction such as supernatant from the biofilm cellular mass and connects biofilm-derived biologically-active material with contacting a biological target in the presence of a carrier.

The disclosure further frames the approach around anti-biofilm activity and immune-support concepts, including targeting biofilm dispersion and quorum sensing. The described compositions combine probiotic organisms with fractions or metabolites associated with biofilms, and include anti-biofilm honey and optional prebiotics and additional components such as hive products, plant or tea derivatives, and Vitamin D3.

Claims Coverage

The document includes two independent claims. Across these independent claims, the core coverage includes three main inventive features: producing a biologically-active composition from reactor-grown microbial biofilm cellular mass, harvesting to obtain that fraction, and combining it with an appropriate carrier for contacting a microbiome or microbes.

Microbiome manipulation by contacting with reactor-grown biofilm fraction composition

A method for manipulating a microbiome comprising contacting the microbiome with a biologically-active composition produced by growing a microbial biofilm within a reactor vessel with a biological growth medium, harvesting the biofilm by removing the biofilm from the reactor vessel to obtain a fraction comprising biologically-active biofilm cellular mass, and combining the fraction with an appropriate carrier to form the biologically-active composition.

Antimicrobial contacting using reactor-grown biofilm fraction composition

An antimicrobial method comprising contacting microbes with a biologically-active composition produced by growing a microbial biofilm within a reactor vessel with a biological growth medium, harvesting the biofilm by removing the biofilm from the reactor vessel to obtain a fraction comprising biologically-active biofilm cellular mass, and combining the fraction with an appropriate carrier to form the biologically active composition.

Both independent claims are centered on contacting a target with a biologically-active composition that is made by reactor-grown microbial biofilm production, harvesting to obtain a biofilm cellular-mass fraction, and combining that fraction with an appropriate carrier.

Stated Advantages

Not explicitly described in patent.

Documented Applications

Topical/local delivery on ocular surfaces (e.g., ocular drops).

Topical/local delivery on sinonasal surfaces (e.g., nasal sprays or rinses).

Topical/local delivery on dermal surfaces (e.g., gels/soaps).

Topical/local delivery on dental and periodontal sites (e.g., toothpaste and periodontal curettage agent).

Topical/local delivery on pulmonary surfaces (e.g., inhalants).

Application to environmental or inert surfaces (e.g., environmental anti-biofilm spray).

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.